(STAT News) – In a global first, some travelers and laboratory researchers who are at risk of contracting chikungunya will soon be allowed to be vaccinated against the virus. A committee of vaccine experts recommended Wednesday that those select groups of people should be offered access to the new vaccine, Ixchiq, which is made by Valneva Austria GmbH. (Read More)